Literature DB >> 24715275

[Coagulation disorders in the intensive care station].

C Hart1, M Spannagl.   

Abstract

Coagulation disorders are frequently encountered in the intensive care unit (ICU) and are challenging due to a variety of potential etiologies. Critically ill patients with coagulation abnormalities may present with an increased risk of bleeding, show coagulation activation resulting in thromboembolism, or have no specific symptoms. Hemostatic abnormalities observed in ICU patients range from isolated thrombocytopenia or prolonged global clotting tests to complex and life-threatening coagulation defects. Successful management of coagulation disorders requires prompt and accurate identification of the underlying cause. This review describes the most frequently occurring diagnoses found in intensive care patients with thrombocytopenia and coagulation test abnormalities and summarizes appropriate diagnostic interventions and current approaches to differential diagnosis.

Entities:  

Mesh:

Year:  2014        PMID: 24715275     DOI: 10.1007/s00108-013-3422-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  13 in total

Review 1.  Hematologic disorders in critically ill patients.

Authors:  Kelly W Mercer; B Gail Macik; Michael E Williams
Journal:  Semin Respir Crit Care Med       Date:  2006-06       Impact factor: 3.119

Review 2.  Coagulopathy in critically ill patients: part 2-soluble clotting factors and hemostatic testing.

Authors:  Arthur P Wheeler; Todd W Rice
Journal:  Chest       Date:  2010-01       Impact factor: 9.410

Review 3.  Coagulopathy in critically ill patients: part 1: platelet disorders.

Authors:  Todd W Rice; Arthur P Wheeler
Journal:  Chest       Date:  2009-12       Impact factor: 9.410

Review 4.  How to approach thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

5.  Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.

Authors:  Fabrice Thiolliere; Anne Françoise Serre-Sapin; Jean Reignier; Marcel Benedit; Jean Michel Constantin; Christine Lebert; Dominique Guélon; Jean François Timsit; Bertrand Souweine
Journal:  Intensive Care Med       Date:  2013-06-06       Impact factor: 17.440

Review 6.  How I treat the acquired von Willebrand syndrome.

Authors:  Andreas Tiede; Jacob H Rand; Ulrich Budde; Arnold Ganser; Augusto B Federici
Journal:  Blood       Date:  2011-05-03       Impact factor: 22.113

Review 7.  Drug-induced thrombocytopenia: pathogenesis, evaluation, and management.

Authors:  James N George; Richard H Aster
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 8.  Heparin-induced thrombocytopenia in intensive care patients.

Authors:  Kathleen Selleng; Sixten Selleng; Andreas Greinacher
Journal:  Semin Thromb Hemost       Date:  2008-10-27       Impact factor: 4.180

9.  Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.

Authors:  M Levi; C H Toh; J Thachil; H G Watson
Journal:  Br J Haematol       Date:  2009-02-12       Impact factor: 6.998

Review 10.  Heparin-induced thrombocytopenia in the ICU: an overview.

Authors:  Yasser Sakr
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.